Hormonal control of calcium homeostasis

Clinical Chemistry

Volumn 45, Issue 8 II, 1999, Pages 1347-1352

  Mundy, Gregory R ^a   Guise, Theresa A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D DERIVATIVE;

CALCIUM BALANCE; CALCIUM TRANSPORT; CONFERENCE PAPER; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; PARATHYROID GLAND;

EID: 0032847385     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.8.1347     Document Type: Conference Paper

References (72)

1. Mundy GR. Calcium homeostasis: hypercalcemia and hypocalcemia. London: Martin Dunitz, 1990:1-16.
2. Mallette LE. Regulation of blood calcium in humans. Endocrinol Metab Clin N Am 1989;18:601-10.
3. Barger-Lux MJ, Heaney RP, Recker RR. Time course of calcium absorption in humans: evidence for a colonic component. Calcif Tissue Int 1989;44:308-11.
4. Yanagawa N, Lee DBN. Renal handling of calcium and phosphorus. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven Press, 1992:3-40.
5. Aurbach GD, Marx SJ, Spiegel AM. Parathyroid hormone, calcitonin, and the calciferols. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. Philadelphia: WB Saunders, 1992: 1397-517.
6. Parfitt AM. The actions of parathyroid hormone on bone. Relation to bone remodeling and turnover, calcium homeostasis and metabolic bone disease. Metabolism 1976;25:909-55.
7. Parfitt AM. Equilibrium and disequilibrium hypercalcemia: new light on an old concept. Metab Bone Dis Relat Res 1979;1:279-93.
8. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Investig 1983;72:1396-409.
9. Parfitt AM. Bone and plasma calcium homeostasis. Bone 1987; 8:S1-8.
10. Parfitt AM. Plasma calcium control at quiescent bone surfaces: a new approach to the homeostatic function of bone lining cells. Bone 1989;10:87-8.
11. Parfitt AM, Braunstein GD, Katz A. Radiation-associated hyperparathyroidism: comparison of adenoma growth rates, inferred from weight and duration of latency, with prevalence of mitosis. J Clin Endocrinol Metab 1993;77:1318-22.
12. Neuman NW. Blood:bone equilibrium. Calcif Tissue Int 1982;34: 117-20.
13. Bushinsky DA, Chabala JM, Levi-Setti R. Ion microprobe analysis of mouse calvariae in vitro: evidence for a "bone membrane". Am J Physiol 1989;256:E152-8.
14. Levinskas GJ, Neuman WF. The solubility of bone mineral. Solubility studies of synthetic hydroxyapatite. J Physiol Chem 1955; 59:164-8.
15. Brown EM. PTH secretion in vivo and in vitro. Miner Electrolyte Metab 1982;8:130-50.
16. Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983;56:572-81.
17. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyper-parathyroidism. Cell 1993;75:1297-303.
18. Finegold DN, Armitage MM, Galiani M, Matise TC, Pandian MR, Perry YM, et al. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatr Res 1994;36:414-7.
19. 2+-sensing receptor gene mutation. Nat Genet 1994;8:303-7.
20. Russell J, Lettiere D, Sherwood LM. Direct regulation by calcium of cytoplasmic messenger RNA coding for pre-pro-parathyroid hormone in isolated bovine parathyroid cells. J Clin Investig 1983; 72:1851-5.
21. Silver J, Russell J, Sherwood LM. Regulation by vitamin D metabolites of messenger RNA for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A 1985;82: 4270-3.
22. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Investig 1986;78:1296-301.
23. Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991;254:1024-6.
24. Segre GV, Niall HD, Habener JF, Potts JT Jr. Metabolism of parathyroid hormone: physiologic and clinical significance. Am J Med 1974;56:774-84.
25. Martin KJ, Hruska KA, Greenwalt A, Klahr S, Slatopolsky E. Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake. J Clin Investig 1976;58:781-8.
26. Hruska KA, Korkor A, Martin K, Slatopolsky E. Peripheral metabolism of intact parathyroid hormone: role of liver and kidney and the effect of chronic renal failure. J Clin Investig 1981;67: 885-92.
27. D'Amour P, Huet P, Segre GV, Rosenblatt M. Characteristics of bovine parathyroid hormone extraction by dog liver in vitro. Am J Physiol 1981;241:E208-14.
28. Segre GV, Perkins AS, Witters LA, Potts JT. Metabolism of parathyroid hormone by isolated rat Kupffer cells and hepatocytes. J Clin Investig 1981;67:449-57.
29. Segre GV, D'Amour P, Hultman A, Potts JT. Effects of hepatectomy, nephrectomy and nephrectomy/uremia on the metabolism of parathyroid hormone in the metabolism of parathyroid hormone in the rat. J Clin Investig 1981;67:439-48.
30. Segre GV, D'Amour P, Potts JT. Metabolism of radioiodinated bovine parathyroid hormone in the rat. Endocrinology 1976;99: 1645-52.
31. Hruska KA, Kopeiman R, Rutherford WE, Klahr S, Slatopolsky E, Greenwalt A, et al. Metabolism of immunoreactive parathyroid hormone in the dog: the role of the kidney and the effects of chronic renal disease. J Clin Investig 1975;56:39-48.
32. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 1991;51:3059-61.
33. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa Ung K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364-7.
34. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A 1987;84:5048-52.
35. Stewart AF, Wu T, Goumas D, Burtis WJ, Broadus AE. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun 1987;146:672-8.
36. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, et al. Parathyroid hormone-like protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone. J Clin Investig 1987;80:1803-7.
37. Motokura T, Fukumoto S, Matsumoto T, Takahashi S, Fujita A, Yamashita T, et al. Parathyroid hormone related protein in adult T-cell leukemia-lymphoma. Ann Intern Med 1989;111:484-8.
38. Yates AJP, Gutierrez GE, Smolens P, Travis PS, Katz MS, Aufdemorte TB, et al. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption and bone metabolism. J Clin Investig 1988; 81:932-8.
39. Kukreja SC, Shevrin DH, Wimbiscus SA, Ebeling PR, Danks JA, Rodda CP, et al. Antibodies to parathyroid hormone-related protein lower serum calcium in athyrnic mouse models of malignancy-associated hypercalcemia due to human tumors. J Clin Investig 1988;82:1798-802.
40. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Investig 1996;98:1544-9.
41. Yin JJ, Chirgwin JM, Dallas M, Grubbs BG, Massague J, Mundy GR, et al. Blockade of TGFβ signaling inhibits parathyroid hormone-related protein (PTHrP) secretion by breast cancer cells and the development of bone metastasis. J Clin Investig 1999;103:197-206.
42. Budayr AA, Halloran BP, King JC, Diep D, Nissenson RA, Strewler GJ. High levels of a parathyroid hormone-like protein in milk. Proc Natl Acad Sci U S A 1989;86:7183-5.
43. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
44. Bruns DE, Bruns ME. Parathyroid hormone-related protein in benign lesions. Am J Clin Pathol 1996;105:377-9.
45. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid-related peptide gene. Genes Dev 1994;8:277-89.
46. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A 1996;93:19240-5.
47. Lanske B, Karaplis AC, Lee, K, Luz A, Vortkakmp A, Pirro A, et al. PTH/PTHrP receptor in early development and Indian hedgehog-related bone growth. Science 1996;273:663-6.
48. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996;273:613-22.
49. Usdin TB, Gruber C, Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 1995;270:15455-8.
50. Usdin TB, Bonner TI, Harta G, Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 1996;137:4285-97.
51. Behar V, Pines M, Nakamoto C, Greenberg Z, Bisello A, Stueckle SM, et al. The human PTH-2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor. Endocrinology 1996;137:2748-57.
52. Deftos LJ. Calcitonin. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Raven Press, 1993:70-6.
53. Barbot N, Calmettes C, Schuffenecker I, Saint-Andre JP, Franc B, Rohmer V, et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screen in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 1994;78:114-20.
54. Friedman J, Au W, Raisz LG. Responses of fetal rat bone to thyrocalcitonin in tissue culture. Endocrinology 1968;82:149-56.
55. Heersche JNM, Marcus R, Aurbach GD. Calcitonin and the formation of 3′,5′-AMP in bone and kidney. Endocrinology 1974;94: 241-7.
56. Moonga BS, Alam AS, Bevis PJ, Avaldi F, Soncini R, Huang CL, et al. Regulation of cytosolic free calcium in isolated osteoclasts by calcitonin. J Endocrinol 1992;132:241-9.
57. Chambers TJ, Magnus CJ. Calcitonin alters the behavior of isolated osteoclasts. J Pathol 1982;136:27-40.
58. Lin HY, Harris TL, Flannery MS, Arufto A, Kaji EH, Gorn A, et al. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 1991;254:1022-4.
59. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD. Down regulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Investig 1995;95:167-71.
60. 3. Ann Rev Nutr 1988;8:375-99.
61. 3-1α-hydroxylase in the rat kidney. J Clin Investig 1982;70:135-40.
62. Bell NH. Vitamin D-endocrine system. J Clin Investig 1985;76:1-6.
63. DeLuca HR. Metabolism and mechanism of action of vitamin D-1982. In: Peck WA, ed. Bone and mineral research annual 1. Princeton: Excerpta Medica, 1983:7-73.
64. Norman AW, Roth J, Orci L. The vitamin D endocrine system: steroid metabolism, hormone, receptors, and biological response (calcium binding proteins). Endocr Rev 1982;3:331-66.
65. Gkonos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med 1984;311:1683-5.
66. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horast RL. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 1981;305:440-3.
67. 3: biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism. J Clin Endocrinol Metab 1986;62:192-6.
68. Holtrop ME, Cox KA, Clark MB, Holick MF, Anast CS. 1,25-dihydroxycholicalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology 1981;108: 2293-301.
69. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988;122:1373-82.
70. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80.
71. St-Arnaud R, Glorieux FH. 24,25-Dihydroxyvitamin D - active metabolite or inactive catabolite? Endocrinology 1998;139:3371-4.
72. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, et al. Two nuclear signalling pathways for vitamin D. Nature 1993;361:657-60.